Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non–small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)
Nasser Khaled Altorki, Xiaofei Wang, Bryce Damman et al. · Journal of Thoracic and Cardiovascular Surgery · 2023
Cited by 120 works. doi:10.1016/j.jtcvs.2023.07.008
Authors
- Nasser Khaled Altorki
- Xiaofei Wang
- Bryce Damman
- Jennifer Mentlick
- Rodney Jerome Landreneau
- Dennis A. Wigle
- David Randolph Jones
- Massimo Conti
- Ahmad S. Ashrafi
- Moïshe Liberman
- Marc E. de Perrot
- John D. Mitchell
- Robert J. Keenan
- THOMAS L BAUER
- Daniel Miller
- Thomas E. Stinchcombe
References
- A Proportional Hazards Model for the Subdistribution of a Competing Risk
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
- Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
- Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
- Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
- Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
- Diameter of Non-small Cell Lung Cancer Correlates With Long-term Survival
- Sublobar Resection for Clinical Stage IA Non–small-cell Lung Cancer in the United States
- The Society of Thoracic Surgeons General Thoracic Surgery Database: 2022 Update on Outcomes and Research
- Report from the European Society of Thoracic Surgeons Database 2017: patterns of care and perioperative outcomes of surgery for malignant lung neoplasm